Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Novo Nordisk concludes Japanese agreement for levormeloxifene

March 31, 1998

Kissei presents promising new agent for premature labor

March 31, 1998

P&U develops antidiabetic amino- and diaminoguanidines

March 31, 1998

FDA clears pravastatin for stroke prevention

March 31, 1998

IND filed for tissue-selective estrogen compound

March 30, 1998

FDA approves Viagra; first oral treatment for ED on the way to market

March 30, 1998

Focus on agents for estrogen deprivation continues at Lilly

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...